These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Troglitazone and related compounds: therapeutic potential beyond diabetes. Fujiwara T; Horikoshi H Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164 [TBL] [Abstract][Full Text] [Related]
33. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes. Teter ML Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019 [No Abstract] [Full Text] [Related]
34. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525 [TBL] [Abstract][Full Text] [Related]
36. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Kruszynska YT; Yu JG; Olefsky JM; Sobel BE Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202 [TBL] [Abstract][Full Text] [Related]
37. Lipoatrophy, lipodystrophy, and insulin resistance. Ganda OP Ann Intern Med; 2000 Aug; 133(4):304-6. PubMed ID: 10929174 [No Abstract] [Full Text] [Related]
38. Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM. Morita H; Oki Y; Ito T; Ohishi H; Suzuki S; Nakamura H Diabetes Care; 2001 Apr; 24(4):788-9. PubMed ID: 11315852 [No Abstract] [Full Text] [Related]
39. Treatment of hyperinsulinaemia in polycystic ovary syndrome? van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218 [No Abstract] [Full Text] [Related]
40. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Scheen AJ; Lefèbvre PJ Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]